Abstract: | Objective To investigate the clinical effect of moxibustion as the adjuvant therapy for novel coronavirus pneumonia (NCP), and to provide a reference for clinical application. Methods A retrospective analysis was performed for the clinical data of 7 patients who met the diagnostic criteria for common NCP, and the assessment indices included duration of cardinal symptoms (fever, cough, and fatigue), disappearance rate of cardinal symptoms, traditional Chinese medicine (TCM) syndrome score, clearance time of nucleic acid, and length of hospital stay. Results Durations of fever, cough, and fatigue were 1-10 days (median 6 days), 4-10 days (median 5 days), and 4-8 days (median 6 days), respectively, and the disappearance rates of fever, cough, and fatigue were 6/6, 4/5, and 3/5, respectively. There was a significant change in TCM syndrome score after treatment (t=9.34, P<0.05). The clearance time of nucleic acid was 10-32 days (median 19 days), and the length of hospital stay was 14-35 days (median 22 days). Conclusion As the adjuvant therapy for NCP, moxibustion can shorten the duration of fever, cough, and fatigue, effectively relieve TCM syndrome, and shorten the length of hospital stay. |